首頁
Ani Pharmaceuticals

11月 2025Ani Pharmaceuticals的市場佔有率分析

ani pharmaceuticals is an integrated specialty pharmaceutical company developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals.

健康 > 生物技術和製藥

域名anipharmaceuticals.com

成立年份1996

僱員501 - 1000

年度營收$200M - $500M

Ani Pharmaceuticals

顯示Ani Pharmaceuticals的主要網站流量和參與度資訊（包含公司地區）

anipharmaceuticals.com
alimerasciences.com
novitiumpharma.com

查看更多網站流量與參與度資訊

Ani Pharmaceuticals截至 11月 2025 的總收入為 200M - 500M

Ani Pharmaceuticals 熱門網域產生的總收入

Ani Pharmaceuticals 熱門網域 3 年內的總收入

Ani Pharmaceuticals 熱門網域的總收入

anipharmaceuticals.com200M - 500M

alimerasciences.com50M - 75M

novitiumpharma.com15M - 25M

透過銷售情報查看更多內容

Ani Pharmaceuticals的熱門網域總造訪量

了解Ani Pharmaceuticals市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

anipharmaceuticals.com8K

alimerasciences.com25

novitiumpharma.com1.1K

透過銷售情報查看更多內容

Ani Pharmaceuticals的熱門網域平均造訪時長

分析Ani Pharmaceuticals參與度指標。

過去 3 個月平均造訪時長

子公司細目

anipharmaceuticals.com00:00:34

novitiumpharma.com00:00:01

透過銷售情報查看更多內容

Ani Pharmaceuticals的熱門網域平均頁面瀏覽量

了解Ani Pharmaceuticals如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

anipharmaceuticals.com2.52

alimerasciences.com1.03

novitiumpharma.com1.34

透過銷售情報查看更多內容

Ani Pharmaceuticals按網域劃分的熱門競爭對手

11月 2025的熱門類似網站，依相似度排名

otsuka.com公司名Otsuka Holdings Co., Ltd.僱員> 10001總部日本, Chiyoda-ku年度營收> $1B訪問總量1.9M健康 > 生物技術和製藥

使用的熱門技術Ani Pharmaceuticals

这些是Ani Pharmaceuticals顶级域名使用的行业网站技术

內容管理系統 (3)

WordPress

小工具 (3)

reCAPTCHA

付費廣告 (2)

Google Adsense

市場行銷 (2)

Google Marketing Platform

更多技術

7

檢視所有

新聞與訊號來自Ani Pharmaceuticals

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞ANI Pharmaceuticals, Inc. launched Pentoxifylline Extended-Release Tablets, USP 400 mg on Jan 23rd '24.On January 23, 2024, ANI Pharmaceuticals unveiled its Pentoxifylline Extended-Release (ER) Tablets, USP 400 mg, offering a generic alternative to Trental(R).

新聞ANI Pharmaceuticals, Inc. attends event 2025 Jefferies Global Healthcare Conference.PRINCETON, N.J., May 27, 2025 (GLOBE NEWSWIRE) - ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2025 Jefferies Global Healthcare Conference in New York City as follows:

新聞ANI Pharmaceuticals, Inc. attends event H.C. Wainwright 3rd Annual BioConnect Investor Conference.PRINCETON, N.J., May 12, 2025 (GLOBE NEWSWIRE) - ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ as follows: